Global In Vivo and In Vitro ADME and PK Market Growth (Status and Outlook) 2021-2026

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global In Vivo and In Vitro ADME and PK Market Size 2016-2026
  • 2.1.2 In Vivo and In Vitro ADME and PK Market Size CAGR by Region 2020 VS 2021 VS 2026
• 2.2 In Vivo and In Vitro ADME and PK Segment by Type
  • 2.2.1 Small Molecules
  • 2.2.2 Small Molecules
• 2.3 In Vivo and In Vitro ADME and PK Market Size by Type
  • 2.3.1 Global In Vivo and In Vitro ADME and PK Market Size CAGR by Type
  • 2.3.2 Global In Vivo and In Vitro ADME and PK Market Size Market Share by Type (2016-2021)
• 2.4 In Vivo and In Vitro ADME and PK Segment by End User
  • 2.4.1 Biopharmaceutical Companies
  • 2.4.2 Government and Academic Institutes
  • 2.4.3 Others
• 2.5 In Vivo and In Vitro ADME and PK Market Size by End User
  • 2.5.1 Global In Vivo and In Vitro ADME and PK Market Size CAGR by End User
  • 2.5.2 Global In Vivo and In Vitro ADME and PK Market Size Market Share by End User (2016-2021)

3 In Vivo and In Vitro ADME and PK Market Size by Players

• 3.1 In Vivo and In Vitro ADME and PK Market Size Market Share by Players
  • 3.1.1 Global In Vivo and In Vitro ADME and PK Revenue by Players (2019-2021E)
  • 3.1.2 Global In Vivo and In Vitro ADME and PK Revenue Market Share by Players (2019-2021E)
• 3.2 Global In Vivo and In Vitro ADME and PK Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 In Vivo and In Vitro ADME and PK by Regions

• 4.1 In Vivo and In Vitro ADME and PK Market Size by Regions (2016-2021)
• 4.2 Americas In Vivo and In Vitro ADME and PK Market Size Growth (2016-2021)
• 4.3 APAC In Vivo and In Vitro ADME and PK Market Size Growth (2016-2021)
• 4.4 Europe In Vivo and In Vitro ADME and PK Market Size Growth (2016-2021)
• 4.5 Middle East & Africa In Vivo and In Vitro ADME and PK Market Size Growth (2016-2021)

5 Americas

• 5.1 Americas In Vivo and In Vitro ADME and PK Market Size by Country (2016-2021)
• 5.2 Americas In Vivo and In Vitro ADME and PK Market Size by Type (2016-2021)
• 5.3 Americas In Vivo and In Vitro ADME and PK Market Size by End User (2016-2021)
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Brazil

6 APAC

• 6.1 APAC In Vivo and In Vitro ADME and PK Market Size by Region (2016-2021)
• 6.2 APAC In Vivo and In Vitro ADME and PK Market Size by Type (2016-2021)
• 6.3 APAC In Vivo and In Vitro ADME and PK Market Size by End User (2016-2021)
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia

7 Europe

• 7.1 Europe In Vivo and In Vitro ADME and PK by Country (2016-2021)
• 7.2 Europe In Vivo and In Vitro ADME and PK Market Size by Type (2016-2021)
• 7.3 Europe In Vivo and In Vitro ADME and PK Market Size by End User (2016-2021)
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia

8 Middle East & Africa

• 8.1 Middle East & Africa In Vivo and In Vitro ADME and PK by Region (2016-2021)
• 8.2 Middle East & Africa In Vivo and In Vitro ADME and PK Market Size by Type (2016-2021)
• 8.3 Middle East & Africa In Vivo and In Vitro ADME and PK Market Size by End User (2016-2021)
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global In Vivo and In Vitro ADME and PK Market Forecast

• 10.1 Global In Vivo and In Vitro ADME and PK Forecast by Regions (2021-2026)
  • 10.1.1 Global In Vivo and In Vitro ADME and PK Forecast by Regions (2021-2026)
  • 10.1.2 Americas In Vivo and In Vitro ADME and PK Forecast
  • 10.1.3 APAC In Vivo and In Vitro ADME and PK Forecast
  • 10.1.4 Europe In Vivo and In Vitro ADME and PK Forecast
  • 10.1.5 Middle East & Africa In Vivo and In Vitro ADME and PK Forecast
• 10.2 Americas In Vivo and In Vitro ADME and PK Forecast by Countries (2021-2026)
  • 10.2.1 United States In Vivo and In Vitro ADME and PK Market Forecast
  • 10.2.2 Canada In Vivo and In Vitro ADME and PK Market Forecast
  • 10.2.3 Mexico In Vivo and In Vitro ADME and PK Market Forecast
  • 10.2.4 Brazil In Vivo and In Vitro ADME and PK Market Forecast
• 10.3 APAC In Vivo and In Vitro ADME and PK Forecast by Region (2021-2026)
  • 10.3.1 China In Vivo and In Vitro ADME and PK Market Forecast
  • 10.3.2 Japan In Vivo and In Vitro ADME and PK Market Forecast
  • 10.3.3 Korea In Vivo and In Vitro ADME and PK Market Forecast
  • 10.3.4 Southeast Asia In Vivo and In Vitro ADME and PK Market Forecast
  • 10.3.5 India In Vivo and In Vitro ADME and PK Market Forecast
  • 10.3.6 Australia In Vivo and In Vitro ADME and PK Market Forecast
• 10.4 Europe In Vivo and In Vitro ADME and PK Forecast by Country (2021-2026)
  • 10.4.1 Germany In Vivo and In Vitro ADME and PK Market Forecast
  • 10.4.2 France In Vivo and In Vitro ADME and PK Market Forecast
  • 10.4.3 UK In Vivo and In Vitro ADME and PK Market Forecast
  • 10.4.4 Italy In Vivo and In Vitro ADME and PK Market Forecast
  • 10.4.5 Russia In Vivo and In Vitro ADME and PK Market Forecast
• 10.5 Middle East & Africa In Vivo and In Vitro ADME and PK Forecast by Region (2021-2026)
  • 10.5.1 Egypt In Vivo and In Vitro ADME and PK Market Forecast
  • 10.5.2 South Africa In Vivo and In Vitro ADME and PK Market Forecast
  • 10.5.3 Israel In Vivo and In Vitro ADME and PK Market Forecast
  • 10.5.4 Turkey In Vivo and In Vitro ADME and PK Market Forecast
  • 10.5.5 GCC Countries In Vivo and In Vitro ADME and PK Market Forecast
• 10.6 Global In Vivo and In Vitro ADME and PK Forecast by Type (2021-2026)
• 10.7 Global In Vivo and In Vitro ADME and PK Forecast by End User (2021-2026)

11 Key Players Analysis

• 11.1 Charles River
  • 11.1.1 Charles River Company Information
  • 11.1.2 Charles River In Vivo and In Vitro ADME and PK Product Offered
  • 11.1.3 Charles River In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
  • 11.1.4 Charles River Main Business Overview
  • 11.1.5 Charles River Latest Developments
• 11.2 Labcorp
  • 11.2.1 Labcorp Company Information
  • 11.2.2 Labcorp In Vivo and In Vitro ADME and PK Product Offered
  • 11.2.3 Labcorp In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
  • 11.2.4 Labcorp Main Business Overview
  • 11.2.5 Labcorp Latest Developments
• 11.3 ICON
  • 11.3.1 ICON Company Information
  • 11.3.2 ICON In Vivo and In Vitro ADME and PK Product Offered
  • 11.3.3 ICON In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
  • 11.3.4 ICON Main Business Overview
  • 11.3.5 ICON Latest Developments
• 11.4 Syneos Health
  • 11.4.1 Syneos Health Company Information
  • 11.4.2 Syneos Health In Vivo and In Vitro ADME and PK Product Offered
  • 11.4.3 Syneos Health In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
  • 11.4.4 Syneos Health Main Business Overview
  • 11.4.5 Syneos Health Latest Developments
• 11.5 Envigo
  • 11.5.1 Envigo Company Information
  • 11.5.2 Envigo In Vivo and In Vitro ADME and PK Product Offered
  • 11.5.3 Envigo In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
  • 11.5.4 Envigo Main Business Overview
  • 11.5.5 Envigo Latest Developments
• 11.6 Curia
  • 11.6.1 Curia Company Information
  • 11.6.2 Curia In Vivo and In Vitro ADME and PK Product Offered
  • 11.6.3 Curia In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
  • 11.6.4 Curia Main Business Overview
  • 11.6.5 Curia Latest Developments
• 11.7 Evotec
  • 11.7.1 Evotec Company Information
  • 11.7.2 Evotec In Vivo and In Vitro ADME and PK Product Offered
  • 11.7.3 Evotec In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
  • 11.7.4 Evotec Main Business Overview
  • 11.7.5 Evotec Latest Developments
• 11.8 Bioduro-Sundia
  • 11.8.1 Bioduro-Sundia Company Information
  • 11.8.2 Bioduro-Sundia In Vivo and In Vitro ADME and PK Product Offered
  • 11.8.3 Bioduro-Sundia In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
  • 11.8.4 Bioduro-Sundia Main Business Overview
  • 11.8.5 Bioduro-Sundia Latest Developments
• 11.9 Lonza
  • 11.9.1 Lonza Company Information
  • 11.9.2 Lonza In Vivo and In Vitro ADME and PK Product Offered
  • 11.9.3 Lonza In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
  • 11.9.4 Lonza Main Business Overview
  • 11.9.5 Lonza Latest Developments
• 11.10 WuXi AppTec
  • 11.10.1 WuXi AppTec Company Information
  • 11.10.2 WuXi AppTec In Vivo and In Vitro ADME and PK Product Offered
  • 11.10.3 WuXi AppTec In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
  • 11.10.4 WuXi AppTec Main Business Overview
  • 11.10.5 WuXi AppTec Latest Developments

11. IQVIA

• 11.11.1 IQVIA Company Information
• 11.11.2 IQVIA In Vivo and In Vitro ADME and PK Product Offered